Literature DB >> 12078925

Myocardial infarction in sickle cell disease.

Ishak A Mansi1, Fred Rosner.   

Abstract

Vasculo-occlusive crisis with organ infarctions occur in sickle cell disease (SCD). However, heart infarction is not commonly reported. We reviewed 19 cases of documented myocardial infarction (MI) in SCD patients. The true incidence may be higher because the diagnosis was often made at autopsy and was overshadowed during life by other musculoskeletal symptoms. Electrocardiography is frequently unhelpful. Skeletal muscle enzymes confound serum cardiac enzyme interpretation. The mechanism of MI in SCD is not exactly known, as coronary angiography is usually normal. MI frequently occurs in association with hypoxia, cor pulmonale, anemia, sepsis, acidosis, and renal failure. The aim of this article is to increase awareness for this complication and to prompt prospective studies to look at treatment strategies for myocardial infarction in SCD.

Entities:  

Mesh:

Year:  2002        PMID: 12078925      PMCID: PMC2594394     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  30 in total

1.  Homage to James B. Herrick: a contemporary look at myocardial infarction and at sickle-cell heart disease: the 32nd Annual Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association.

Authors:  T N James
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

2.  Bilateral central retinal artery occlusion secondary to sickle cell disease.

Authors:  I A Mansi; A M Alkhunaizi; A A Al-Khatti
Journal:  Am J Hematol       Date:  2000-05       Impact factor: 10.047

3.  Elevated platelet count and megathrombocyte number in sickle cell anemia.

Authors:  M L Freedman; S Karpatkin
Journal:  Blood       Date:  1975-10       Impact factor: 22.113

4.  Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium.

Authors:  S L Space; P A Lane; C K Pickett; J V Weil
Journal:  Am J Hematol       Date:  2000-04       Impact factor: 10.047

5.  Sickle cell anemia- clinical manifestations in 100 patients and review of the literature.

Authors:  G Karayalcin; F Rosner; K Y Kim; P Chandra; A J Aballi
Journal:  Am J Med Sci       Date:  1975 Jan-Feb       Impact factor: 2.378

6.  High resistance of the human myocardium to shock and red blood cell aggregation (sludge).

Authors:  G Baroldi
Journal:  Cardiologia       Date:  1969

7.  Sickle cell states and cardiomyopathy. Sudden death due to pulmonary thrombosis and infarction.

Authors:  S Rubler; R A Fleischer
Journal:  Am J Cardiol       Date:  1967-06       Impact factor: 2.778

8.  Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.

Authors:  L De Franceschi; D Bachir; F Galacteros; G Tchernia; T Cynober; D Neuberg; Y Beuzard; C Brugnara
Journal:  Br J Haematol       Date:  2000-02       Impact factor: 6.998

9.  Abnormal rheology of oxygenated blood in sickle cell anemia.

Authors:  S Chien; S Usami; J F Bertles
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

10.  Coagulation fibrinolysis in sickle-cell disease.

Authors:  P A Gordon; G R Breeze; J R Mann; J Stuart
Journal:  J Clin Pathol       Date:  1974-06       Impact factor: 3.411

View more
  11 in total

1.  Brain venular pattern by 7T MRI correlates with memory and haemoglobin in sickle cell anaemia.

Authors:  Enrico M Novelli; C Elizabeth Sarles; Howard Jay Aizenstein; Tamer S Ibrahim; Meryl A Butters; Anne Connelly Ritter; Kirk I Erickson; Caterina Rosano
Journal:  Psychiatry Res       Date:  2015-04-25       Impact factor: 3.222

2.  Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease.

Authors:  Courtney D Fitzhugh; Naudia Lauder; Jude C Jonassaint; Marilyn J Telen; Xiongce Zhao; Elizabeth C Wright; Francis R Gilliam; Laura M De Castro
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

3.  Myocardial ischaemia in sickle cell anaemia: evaluation using a new scoring system.

Authors:  F Bode-Thomas; H I Hyacinth; O Ogunkunle; A Omotoso
Journal:  Ann Trop Paediatr       Date:  2011

4.  Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.

Authors:  Hui Wang; Wei Luo; Jintao Wang; Chiao Guo; Stephanie L Wolffe; Julia Wang; Eddy B Sun; Kori N Bradley; Andrew D Campbell; Daniel T Eitzman
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

Review 5.  Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problem.

Authors:  Paul Chacko; Eric H Kraut; Jay Zweier; Charles Hitchcock; Subha V Raman
Journal:  J Cardiovasc Transl Res       Date:  2012-11-21       Impact factor: 4.132

6.  Increased left main coronary artery dimensions in children with sickle cell disease.

Authors:  Arpan R Doshi; Linda B Pauliks
Journal:  Pediatr Cardiol       Date:  2012-11-28       Impact factor: 1.655

7.  Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.

Authors:  Maria L Jison; Peter J Munson; Jennifer J Barb; Anthony F Suffredini; Shefali Talwar; Carolea Logun; Nalini Raghavachari; John H Beigel; James H Shelhamer; Robert L Danner; Mark T Gladwin
Journal:  Blood       Date:  2004-03-18       Impact factor: 22.113

8.  Myocardial ischaemia in children with sickle cell disease.

Authors:  M de Montalembert; C Maunoury; P Acar; V Brousse; D Sidi; G Lenoir
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

9.  Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease.

Authors:  Kenneth I Ataga; Alan Hinderliter; Julia E Brittain; Susan Jones; Hao Xu; Jianwen Cai; Soyoung Kim; Kirkwood A Pritchard; Cheryl A Hillery
Journal:  Hematology       Date:  2014-05-06       Impact factor: 2.269

Review 10.  Cardiac pathophysiology in sickle cell disease.

Authors:  Oluwabukola Temitope Gbotosho; Michael Taylor; Punam Malik
Journal:  J Thromb Thrombolysis       Date:  2021-03-07       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.